Insulin aspart, recombinant Subcutaneous and Piperacillin and tazobactam
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Piperacillin and tazobactam and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: piperacillin / tazobactam
Brand name: Zosyn
Synonyms: Piperacillin and Tazobactam
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Piperacillin and tazobactam Intravenous
- Insulin aspart, recombinant Subcutaneous-Piperacillin Sodium and Tazobactam Sodium
- Insulin aspart, recombinant Subcutaneous-Piperazine
- Insulin aspart, recombinant Subcutaneous-Pipracil
- Insulin aspart, recombinant Subcutaneous-Piqray
- Insulin aspart, recombinant Subcutaneous-Piqray 200MG Daily Dose
- Piperacillin and tazobactam-Insulin degludec
- Piperacillin and tazobactam-Insulin Degludec (U-100) Prefilled Pens
- Piperacillin and tazobactam-Insulin Degludec (U-100) Vials
- Piperacillin and tazobactam-Insulin Degludec (U-200) Prefilled Pens
- Piperacillin and tazobactam-Insulin degludec and liraglutide
- Piperacillin and tazobactam-Insulin degludec and liraglutide Subcutaneous